Literature DB >> 11193265

Treatment of stroke on an intensive stroke unit: a novel concept.

J Treib1, M T Grauer, R Woessner, M Morgenthaler.   

Abstract

In industrialised nations stroke ranks as number three among causes of death and is the most frequent cause of disability in old age. Demographic changes will result in stroke gaining increasing importance for individuals as well as for society as a whole. Stroke is already a major cost factor for healthcare and social security systems because of its high long-term costs. Therapeutic nihilism, although still widespread among patients and some physicians, is no longer justified. Long-term outcome after stroke can be significantly improved by providing therapy in wards specialised in early rehabilitation, so-called 'stroke units'. Recent magnetic resonance imaging (MRI) and positron emission tomography (PET) studies, as well as lysis therapy studies have shown that the first 3-6 h are crucially important. For this reason, the concept of "intensive stroke units" also called "intensive care stroke units" has been implemented in Germany. The goal of an intensive stroke unit is the optimal care of stroke patients under intensive care conditions for the first 3-4 days with the aim of improving outcome, long-term morbidity, and reducing long-term healthcare costs. Another important objective is the development and research of new therapeutic concepts and approaches that are based on pathophysiological considerations. A further goal is the initiation of specific therapies depending on the suspected underlying pathophysiology, for example, local or systemic thrombolysis, full-dose heparinisation, platelet aggregation inhibitors, oral anticoagulants, neuroprotective agents, decompression craniotomy, sympathomimetically supported volume therapy and hypothermia. A final objective is to minimise the number of complications through intensive monitoring. Basic acute management includes optimal oxygen supply, rapid normalisation of blood glucose and body temperature, volume therapy, maintaining a high blood pressure and cardiac output to improve remaining cerebral perfusion in the presence of ischaemically impaired autoregulation, treating cerebral oedema, prophylaxis of thrombosis, and early mobilisation. Rapid and easy access to computerised tomography (CT), MRI, Doppler and duplex scanning of the brain-supplying blood vessels, and echocardiography is essential. The ready availability of intensive care monitoring (blood pressure, electrocardiography, central venous pressure, transcranial Doppler (TCD), TCD embolism detection, cerebral pressure, electroencephalography and cardiac output is also imperative. We would like to stress at this point that this manuscript is a personal view describing stroke care in Germany. Many of the principles described have not been widely adopted elsewhere, perhaps in part due to a lack of available facilities. However, many of our recommendations are based on logical principles and thus, we feel, bear further scrutiny.

Entities:  

Mesh:

Year:  2000        PMID: 11193265     DOI: 10.1007/s001340000667

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  7 in total

1.  Platelet aggregation inhibition with ticlopidine in the treatment of stroke.

Authors:  C Zauner; G C Funk; R Birnbacher
Journal:  Intensive Care Med       Date:  2001-03       Impact factor: 17.440

2.  The five ps of acute ischemic stroke treatment: parenchyma, pipes, perfusion, penumbra, and prevention of complications.

Authors:  Robert A Felberg; Andrew Naidech
Journal:  Ochsner J       Date:  2003

3.  IL-35 is a Protective Immunomodulator in Brain Ischemic Injury in Mice.

Authors:  Chen Xu; Hao Zhu; Rong Shen; Qian Feng; Hua Zhou; Zhong Zhao
Journal:  Neurochem Res       Date:  2018-06-08       Impact factor: 3.996

Review 4.  Management of massive cerebral infarct.

Authors:  Galen V Henderson
Journal:  Curr Neurol Neurosci Rep       Date:  2004-11       Impact factor: 5.081

5.  Cerebrovascular complications in pediatric intensive care unit.

Authors:  Anil Sachdev; Rachna Sharma; Dhiren Gupta
Journal:  Indian J Crit Care Med       Date:  2010-07

6.  Beneficial effects of stroke-unit care in stroke patients with atrial fibrillation.

Authors:  Hye-Yeon Choi; Joo Hyun Seo; Jae Hoon Yang; Young Dae Kim; Yo Han Jung; Han Jin Cho; Hyo Suk Nam; Ji Hoe Heo
Journal:  Yonsei Med J       Date:  2013-03-01       Impact factor: 2.759

7.  Hydroxyethyl starch 130/0.4 and sodium chloride injection as adjunctive therapy in patients with cerebral hypoperfusion.

Authors:  Junliang Han; Fang Yang; Wenrui Jiang; Guangyun Zhang; Zhirong Liu; Xuedong Liu; Feng Xia; Ya Bai; Junhong He; Manxiang Chao; Gang Zhao
Journal:  BMC Neurol       Date:  2012-10-30       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.